Brain Natriuretic Peptide Market Trends: Product Composition, Brand Comparison, and Technical Advantages
Abstract: The brain natriuretic peptide (BNP) market demonstrates robust growth, driven by expanding diagnostic and therapeutic applications in cardiovascular diseases. Product composition varies by synthesis method (recombinant vs. chemical), impacting purity and bioactivity. Leading brands (e.g., Roche, Abbott) differ in assay sensitivity and specificity, with technical advantages including enhanced stability and reduced cross-reactivity. Key parameters (e.g., half-life, molecular weight) influence clinical utility. Industry trends favor point-of-care testing and lyophilized formulations. Factory certifications (GMP, ISO 13485) and product certificates (CE, FDA) are critical for quality assurance. Selection criteria prioritize batch consistency, logistics (cold-chain compliance), and regulatory compliance. The market outlook remains positive, with increasing R&D investment in next-generation analogs.